Chun Yan | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Dr. Chun Yan | Stem Cell Research | Best Researcher Award

Dr. Chun Yan, Department of Thoracic Surgery, Zhongshan Hospital of Xiamen University, China

Dr. Yan Chun is an Attending Physician at the School of Medicine/Zhongshan Hospital, Xiamen University. With a solid foundation in clinical medicine and surgery, Dr. Chun brings over a decade of experience in thoracic oncology and AI-driven medical research. After earning a Bachelor’s degree from Fujian Medical University, he pursued his Master’s in Surgery at Shanghai Jiao Tong University. Since 2018, Dr. Chun has contributed significantly to clinical practice, medical innovation, and academic research. His current focus includes AI-assisted diagnosis, radiogenomics, and the biomechanics of thoracic surgery. A recognized member of the Minimally Invasive Thoracic Oncology Committee under the Fujian Primary Health Association, he has received multiple accolades for his pioneering work in esophageal cancer therapy. Dr. Chun’s commitment to precision medicine and integration of AI in healthcare highlights his suitability for prestigious research honors and positions him as a leader in translational medical research in China.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Strong Academic Foundation: Dr. Yan Chun holds a Master’s degree in Surgery from Shanghai Jiao Tong University and a Bachelor’s degree in Clinical Medicine, ensuring a robust foundation in both research and clinical practice.

  2. Innovative Research: He leads and participates in cutting-edge projects that integrate AI, radiogenomics, and biomechanical modeling, reflecting a multidisciplinary and forward-thinking approach.

  3. Recognized Excellence: His work has been honored with regional innovation and scientific progress awards, demonstrating tangible contributions to thoracic oncology.

  4. Clinical Expertise: With 7+ years of medical experience, including as an attending physician, he bridges practical medicine with impactful research.

  5. Leadership Role: Serving on a professional committee in minimally invasive thoracic oncology highlights his thought leadership within his specialty.

🧠 Areas for Improvement:

  1. Expanded Publication Record: While impactful, Dr. Chun’s publication portfolio would benefit from a broader presence in international, high-impact journals to boost academic visibility.

  2. International Collaboration: Engaging in cross-border research partnerships could enhance both innovation scope and influence.

  3. Grant Scale: Existing grants are modest in size. Applying for national-level or larger competitive grants could support more ambitious projects.

  4. Mentorship and Training: Documenting roles in mentoring junior researchers or medical students would strengthen his academic leadership profile.

🎓 Education:

Dr. Yan Chun’s academic journey began with a Bachelor of Clinical Medicine (MBBS) from Fujian Medical University (2010–2015), where he gained fundamental clinical knowledge and medical training. He then advanced his specialization in surgery by completing a Master of Surgery (MS) at Shanghai Jiao Tong University (2015–2018), one of China’s top medical institutions. His education emphasized evidence-based clinical practice, surgical skills, and research methodology. During his postgraduate studies, he was actively involved in academic projects, laying a strong foundation for his later research in thoracic oncology and artificial intelligence in medicine. This robust educational background equips him with interdisciplinary expertise, bridging clinical medicine, surgical techniques, and research innovation—especially in radiogenomics and perioperative therapies for esophageal cancer. His training reflects both academic rigor and a forward-looking approach to integrating emerging technologies with healthcare delivery, making him well-prepared to drive impactful research initiatives.

💼 Experience:

Dr. Yan Chun has held progressive roles at Zhongshan Hospital, Xiamen University since 2018. Starting as a Physician (2018–2023), he delivered comprehensive clinical care while engaging in translational research projects. Since July 2023, he has been serving as an Attending Physician, contributing to surgical excellence and AI-assisted diagnostic strategies in thoracic oncology. His hands-on clinical experience is complemented by leadership in grant-funded research, particularly in predictive modeling and biomechanics. Dr. Chun’s involvement in multi-disciplinary teams, collaborations with AI scientists, and contributions to surgical innovation have advanced the care standards in thoracic surgery. He has also actively contributed to institutional and provincial-level scientific programs, showcasing his capability in both practical medicine and medical research. His work stands at the intersection of clinical practice and innovation, and he remains committed to improving outcomes for patients with complex thoracic conditions through precision diagnostics and minimally invasive techniques.

🏅 Awards and Honors:

Dr. Yan Chun has received multiple accolades recognizing his innovative contributions to thoracic oncology and surgical AI. His project, “AI-Assisted Precision Perioperative Individualized Therapy for Esophageal Cancer”, was selected as one of the Top Ten Innovations of the Year by the Xiamen Hospital Association, highlighting its impact on personalized medicine. Another landmark project, “Precision Diagnosis and Treatment Paradigm for Esophageal Squamous Cell Carcinoma Driven by AI and Multi-Omics Integration”, earned him the Third Prize for Scientific and Technological Progress from the Fujian Anti-Cancer Association, underscoring his leadership in advanced cancer care. His awards reflect not only clinical innovation but also excellence in multi-disciplinary research. These honors are a testament to his ability to bridge clinical needs with technological advancements, demonstrating vision, technical skill, and translational impact. They position him as a high-impact researcher contributing meaningfully to China’s evolving healthcare landscape.

🔬 Research Focus:

Dr. Yan Chun’s research is primarily centered on the integration of artificial intelligence, radiogenomics, and thoracic oncology. He leads a government-funded project investigating deep learning-based predictive models for lymph node metastasis and prognosis in esophageal cancer, leveraging imaging-genomics to improve pre- and post-operative decision-making. He also contributed to biomechanical analysis of the NUSS procedure for pectus excavatum, applying finite element modeling to improve surgical outcomes. His work merges clinical data science, image processing, and genomics, aiming to build personalized treatment pathways and enhance minimally invasive approaches. Dr. Chun’s interdisciplinary approach reflects a deep understanding of both computational technologies and real-world clinical challenges. His ambition is to develop AI-powered platforms that augment oncological diagnostics and optimize surgical interventions. Through a combination of hands-on experience and research rigor, he is at the forefront of precision medicine in thoracic surgery, striving for innovation that is both data-driven and patient-centered.

📚 Publications Top Notes:

📖 Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin – Science of the Total Environment, 2024 🌱🫁

🧾 Conclusion:

Dr. Yan Chun demonstrates exceptional promise and maturity as a clinical researcher whose work lies at the confluence of AI, precision medicine, and thoracic surgery. His contributions to the diagnosis and treatment of esophageal cancer through radiogenomic modeling and minimally invasive techniques are both innovative and clinically meaningful. Backed by professional recognition and a strong clinical research ethic, Dr. Chun is a worthy candidate for the Best Researcher Award. With expanded international presence and high-impact publications, he is poised to become a leading figure in the global thoracic oncology research community.

ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Posted on by Cell Biologist

Dr. ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Dr. ALICIA MARIA TAMAYO CARBON , HOSPITAL CLÍNICO QUIRÚRGICO HERMANOS AMEIJEIRAS , Cuba

Dra. C. Alicia María Tamayo Carbón is a highly accomplished specialist in plastic surgery and caumatology at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. With extensive academic and professional qualifications, she holds a medical degree, multiple specializations in comprehensive general medicine, plastic surgery, and caumatology, and is an expert in regenerative therapy. She is a researcher, professor, and author of numerous scientific papers and book chapters. Dra. Tamayo Carbón is recognized for her pioneering work in regenerative therapy using adipose tissue. She has received national recognition with awards like the National Impact Award from ANIR and the Meritorious Researcher Award from CIGB. Dra. Tamayo has collaborated with various institutions on groundbreaking research in regenerative medicine and gender reassignment. She is a prominent member of several professional organizations, contributing significantly to medical advancements in Cuba and beyond.

Publication Profile: 

Orcid

Strengths for the Award:

Dra. Alicia María Tamayo Carbón is an outstanding candidate for the Women Researcher Award due to her extensive contributions to the fields of plastic surgery, caumatology, and regenerative therapy. Her pioneering work in adipose tissue-based regenerative therapy has had a profound impact on the medical community, both nationally and internationally. With 11 ongoing research projects, 125 published journals, and significant collaborations with renowned institutions, her academic and clinical achievements have earned her multiple accolades such as the National Impact Award and Meritorious Researcher Award. Additionally, her leadership roles in scientific councils and her involvement in various groundbreaking projects highlight her influence and dedication to advancing medical practices, particularly in cosmetic and reconstructive surgery, as well as in gender reassignment. Her contributions have also led to the publication of books, patents, and a strong academic presence.

Areas for Improvement:

While Dra. Tamayo’s work is extensive and impactful, expanding her visibility in international collaborations outside of Cuba and increasing her citation index could enhance her global recognition. Further engagement in multidisciplinary collaborations, particularly in the areas of advanced technologies like AI or machine learning in surgery, could be explored to push the boundaries of her work in regenerative therapy.

Education:

Dra. Alicia María Tamayo Carbón’s academic journey reflects her dedication to advancing medical knowledge and practice. She began with a medical degree, followed by first-degree specialization in comprehensive general medicine. Her pursuit of excellence continued as she achieved both first- and second-degree specialization in plastic surgery and caumatology. Additionally, she holds a diploma in healthcare management and a university postgraduate degree in aesthetic medicine from the University of the Atlantic, Barcelona, Spain. Her academic foundation is complemented by a specialization in regenerative therapy, reinforcing her commitment to innovative treatments in her field. Dra. Tamayo Carbón’s academic achievements are paired with a passion for teaching, as she serves as a professor for the Master’s program in Aesthetic Medicine in Barcelona. Her educational path has laid the groundwork for her contributions to regenerative therapy and aesthetic medicine, making her a recognized expert in her field.

Experience:

Dra. Alicia María Tamayo Carbón boasts a rich professional background in plastic surgery and regenerative therapy. As a full professor and researcher, she has significantly contributed to the field of regenerative therapy, particularly in the use of adipose tissue for medical treatments. Her extensive experience is underscored by her clinical work at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. Dra. Tamayo has also held pivotal roles in national and international collaborations, including projects with the Cuban Institute of Hematology and Immunology and CEADEN, focusing on stem cell research and tissue engineering. She has been a key figure in developing regenerative therapy applications for skin disorders, gender reassignment, and reconstructive surgery. Her leadership as the head of the national specialty group and her board membership in the Cuban Society of Plastic Surgery and Caumatology further highlight her influence. Dra. Tamayo’s professional career is marked by continuous advancements in surgical and therapeutic techniques.

Research Focus:

Dra. Alicia María Tamayo Carbón’s research focus lies at the intersection of plastic surgery, regenerative medicine, and tissue engineering. Her groundbreaking work in regenerative therapy, particularly the use of adipose tissue and stem cells for medical treatments, has positioned her as a leader in this field. She has led numerous projects that explore adipose-derived stem cells, nanofat, and tissue engineering, particularly in reconstructive surgery, cosmetic procedures, and gender reassignment. Dra. Tamayo has collaborated with several national and international institutions to explore the phenotypic characterization of stem cells and their application in regenerative therapies. Her work also includes investigating new methods in tissue engineering, such as 3D bioprinting of biodegradable scaffolds for regenerative purposes. She has actively contributed to the development of clinical trials targeting stem cells from umbilical cord adipose tissue. Through her research, Dra. Tamayo Carbón aims to improve patient outcomes and advance the field of regenerative therapy in aesthetic and reconstructive surgery.

Publications Top Notes:

  1. “Utilidad del tejido adiposo en el tratamiento de las deformidades mentonianas. Un rescate de la lipotransferencia” 🦷💉
  2. “Identificación y caracterización de células madre hematopoyéticas en tejido adiposo obtenidas por nanograsa” 🧬🔬
  3. “Masculinización torácica aplicada al tratamiento de la ginecomastia grave” 💪🏽👨‍⚕️
  4. “Restauración volumétrica autóloga en pacientes con hemiatrofia adiposa facial” 🤲🏽💉
  5. “Mastoplastia de aumento, complemento indispensable de feminización en trastornos de identidad de género” 🌸🏥
  6. “Aplicación del protocolo de recuperación posquirúrgica mejorada en la liposucción abdominal” 💪🏼🛏️
  7. “Nanofat, su expansión en la asistencia médica” 🧴⚙️
  8. “Reconstrucción mamaria con colgajo dérmico en cirugía de lesión benigna con alto riesgo de malignidad” 💕🏥
  9. “Activation of the Immune System by Irresponsible use of Modeling Substances” 🦠⚠️
  10. “Tratamiento quirúrgico periorbitario, un enfoque desde la cirugía plástica” 👁️💉

Conclusion:

Dra. C. Alicia María Tamayo Carbón is an exemplary figure in the medical field, particularly in regenerative medicine and plastic surgery. Her groundbreaking research and continuous efforts to improve patient outcomes through innovative therapies make her a deserving candidate for the Research for Women Researcher Award. Her contributions have not only advanced scientific knowledge but also positively impacted clinical practices, demonstrating her exceptional commitment to both research and education. Dra. Tamayo’s expertise, leadership, and sustained contributions solidify her as a leader and an inspiration for future generations of female researchers.

 

 

 

Liren Qian | Stem cell transplantation | Best Researcher Award

Posted on by Cell Biologist

Prof. Dr. Liren Qian | Stem cell transplantation | Best Researcher Award

Prof. Dr. Liren Qian , Chinese PLA General Hospital , China

Dr. Liren Qian, M.D., Ph.D., is a renowned hematologist with extensive experience in both clinical practice and academic research. He currently serves as Vice Director of the Senior Department of Hematology at the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. With his clinical expertise, Dr. Qian specializes in all hematologic subspecialties and is dedicated to the advancement of hematopoietic stem cell transplantation and radiation medicine. He is also a prominent academic editor for several journals, including Stem Cells International and Frontiers in Oncology. Dr. Qian has made significant contributions to the scientific community, particularly in oxidative stress, hematopoietic stem cell transplantation, and chronic graft-versus-host disease. With a career spanning over a decade, Dr. Qian is widely respected for his work in both clinical and research settings.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Liren Qian, M.D., Ph.D., is an esteemed figure in the field of hematology, with extensive expertise in hematologic diseases and stem cell transplantation. His commitment to both clinical care and research, demonstrated by his current leadership role as Vice Director at the Senior Department of Hematology, Chinese PLA General Hospital, showcases his proficiency in managing complex hematologic conditions. As an active academic editor for prestigious journals such as Stem Cells International and Frontiers in Oncology, Dr. Qian also contributes significantly to the scientific community. His consistent involvement in cutting-edge research, reflected in over 40 peer-reviewed publications, primarily focusing on hematopoietic stem cell transplantation, graft-versus-host disease, and oxidative stress in blood disorders, makes him a standout candidate for the Best Researcher Award.

Areas for Improvement:

While Dr. Qian’s research contributions and clinical accomplishments are substantial, there are opportunities for enhancing the impact of his work in terms of global collaboration. Expanding his research into more interdisciplinary areas, particularly in personalized medicine and genetic therapies, could further enrich his contributions to the field. Additionally, greater outreach in terms of mentoring young researchers and expanding his educational programs could enhance his influence within the medical community.

Education:

Dr. Liren Qian earned his M.D. and Ph.D. in Medicine, specializing in hematology, from prestigious institutions in China. Throughout his educational journey, he focused on advancing his knowledge in hematopoietic stem cell transplantation, radiation medicine, and oxidative stress. His rigorous academic training was complemented by hands-on clinical experience, leading to his recognition as a leader in hematology. During his doctoral studies, Dr. Qian focused on the pathophysiology of hematological disorders and innovative treatments, which has influenced his research trajectory. Over the years, Dr. Qian has expanded his expertise through continuous education and involvement in international academic collaborations. His commitment to medical education is evident in his role as a Master’s degree tutor for medical students and his involvement in training resident doctors and interns.

Experience:

Dr. Liren Qian has a distinguished career in hematology, with experience in both clinical and research domains. He has served as Vice Director of the Senior Department of Hematology at the Fifth Medical Center of the Chinese PLA General Hospital since 2021, overseeing both inpatient and outpatient care in all hematologic subspecialties. Prior to this, Dr. Qian was an Associate Chief Physician, Associate Professor, and Master’s degree tutor, where he played a key role in the implementation of experimental research and clinical trials. His experience also includes serving as an attending physician and as the Secretary of Medical Education, where he developed training programs for residents and interns. Dr. Qian’s extensive work in managing hematological conditions and his contributions to clinical trials have established him as a leading expert in hematology, particularly in stem cell transplantation and radiation-induced hematological diseases.

Awards and Honors:

Dr. Liren Qian has received numerous prestigious awards in recognition of his contributions to medicine and research. In 2019, he was honored with the Innovation Talent Project’s Young Talents Award by the Chinese PLA General Hospital, highlighting his excellence in medical research. In 2018, he received the Military Outstanding Professional and Technical Personnel Award from the Central Military Commission of China, further emphasizing his significant role in advancing medical practices within the military health system. Additionally, Dr. Qian was presented with the Outstanding Medical Service Star Award in 2017 by the Navy General Hospital for his exceptional clinical service. His early accomplishments were acknowledged with the Best in Medical Skills Competition Award (2014) and the Outstanding Medical Worker Award (2013) from the same institution. These accolades reflect his dedication to both the clinical and academic spheres of hematology.

Research Focus:

Dr. Liren Qian’s research is focused on hematopoietic stem cell transplantation, oxidative stress in blood disorders, chronic graft-versus-host disease, and innovative therapies for hematologic malignancies. His work on the therapeutic effects of non-preconditioning allogeneic hematopoietic stem cell transplantation in acute radiation injury has garnered significant attention. Dr. Qian is actively involved in experimental research aiming to improve the outcomes of stem cell transplantation, particularly in the treatment of myelodysplastic syndrome and other hematologic diseases. His research also delves into the role of hydrogen-rich water in ameliorating chronic graft-versus-host disease and the potential of mesenchymal stromal cells in radiation-induced hematological injuries. By focusing on oxidative stress and its impact on hematopoiesis, Dr. Qian seeks to enhance the understanding and treatment of various blood disorders. His innovative approach and dedication to advancing clinical care make his research highly impactful in the field of hematology.

Publications Top Notes:

  • Therapeutic effects of non-preconditioning allogeneic hematopoietic stem cell transplantation on acute radiation injury 🌟
  • Hematopoietic Stem Cell Transplantation in the Management of Myelodysplastic Syndrome 📑
  • Extramedullary Hematopoiesis of the Liver and Spleen 💉
  • Hydrogen‐Rich Water Ameliorates Murine Chronic Graft‐versus‐Host Disease through Antioxidation ⚗️
  • Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies 💊
  • Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Phase 2 Trial 🌱
  • Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Acute Radiation Syndrome 💀
  • Medical Application of Hydrogen in Hematological Diseases 🧬
  • Correction: Genetically enhanced T lymphocytes and the intensive care unit 🏥
  • Genetically enhanced T lymphocytes and the intensive care unit 🔬
  • Protein dysregulation in graft versus host disease ⚖️
  • 8-methoxypsoralen activated by ultraviolet A ameliorates acute graft-versus-host disease in a murine model 🧪
  • Advances in the treatment of newly diagnosed primary central nervous system lymphomas 🧠
  • Detection of ATP Level in CD4+ T Lymphocytes in Hematopoietic Stem Cell Transplantation Recipients 💪
  • The inefficacy of micro-transplantation in relapsed acute lymphocytic leukemia 💔

Conclusion:

Dr. Liren Qian is a highly accomplished hematologist whose work in stem cell therapy, clinical hematology, and transplantation research is exemplary. His dual focus on clinical excellence and scientific inquiry positions him as a leader in his field. With his vast experience and commitment to advancing hematology, he is a highly deserving candidate for the Best Researcher Award.